Filipino nurse faces murder raps in UK

Rappler.com
Victorino Chua, 48, is charged for poisoning patients and causing them grievous bodily harm at Stepping Hill hospital. Police is also looking into tampering of medical records

ARRESTED. Filipino nurse Victorino Chua faces murder charges more than two years after the poisoning incident at Stockport's Stepping Hill Hospital. File photo by Andrew Yates/AFP 

MANILA, Philippines – A Filipino nurse working for a British hospital was rearrested Friday, March 28, for the murder of 3 patients poisoned with contaminated medical products.

Eight patients died following the poisoning at Stepping Hill hospital in Stockport, near Manchester in northwest England, in June and July 2011.

Victorino Chua, a 48-year-old father of two children, has been charged with murdering 3 of them: Tracey Arden, 44; Arnold Lancaster, 71; and Derek Weaver, 83.

London’s Daily Star reported that in January 2012, Chua was held on suspicion after the patients’ deaths. Their saline drips were allegedly contaminated with insulin.

The Filipino nurse spent the last two years and one month on bail.

He has also been charged with one count of causing grievous bodily harm with intent, 22 counts of attempting to cause grievous bodily harm with intent, and 8 offenses of attempting to administer poison.

The tampering of medical records is also being investigated, the Daily Star said.

Assistant Chief Constable Steve Heywood of Greater Manchester Police said on Saturday, March 29: “Our thoughts continue to be with those people who were deliberately poisoned and their families.

“From day one we made a commitment to those people, as well as the wider community, to thoroughly and robustly investigate what occurred.

“In close to 3 years we have conducted many painstaking inquiries and engaged with numerous medical experts. We are now at a point where we have charged Victorino Chua with a number of very serious offences.” – with a report from Agence France-Presse/Rappler.com

Add a comment

Sort by

There are no comments yet. Add your comment to start the conversation.